At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 1,814 enrolled
Drug / intervention
Cediranib +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer
In Brief
A Phase 3 clinical trial evaluating Cediranib, Bevacizumab, and 3 other interventions for Colorectal Cancer. Completed, enrolled 1,814 participants across 280 sites in 28 countries.
Detailed Summary
The purpose of this study is to see if Cediranib in combination with FOLFOX is effective in treating metastatic colorectal cancer and to see how it compares with Avastin (Bevacizumab) in combination with FOLFOX.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Cancer
CountriesAustralia, Austria, Belgium, Canada, Czechia, Egypt, Finland, France, Germany, Hungary, India, Israel, Italy, Latvia, Malta, Philippines, Poland, Russia, Slovakia, South Africa, Spain, Taiwan, Thailand, Turkey (Türkiye), Ukraine, United Kingdom, United States, Vietnam
Collaborators--
Timeline
Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2006
First PostedOct 2006
Primary CompletionNov 2009
Study CompletionAug 2015
TodayJul 2026
First PostedOct 5, 2006
Enrollment StartAug 30, 2006
Primary CompletionNov 15, 2009
Study CompletionAug 19, 2015
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 19.7 years ago
Interventions
Cediranibdrug
oral tablet once daily
Bevacizumabdrug
intravenous infusion
5-fluorouracil ( in FOLFOX)drug
intravenous infusion
Leucovorin (in FOLFOX)drug
intravenous infusion
Oxaliplatin (in FOLFOX)drug
intravenous infusion